Research study Program year 2023 Source: CMS Open Payments

Ph IIb dose finding vs placebo in patients with Ob

Research payments

$3,716,204

49 payments

Through program year 2023, $3,716,204 in research payments was reported against Ph IIb dose finding vs placebo in patients with Ob, across 49 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..

Paid by: Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$147,834	8
2022	Research	$1,269,673	12
2021	Research	$2,280,197	27
2020	Research	$18,500	2

Breakdown

Who paid Research payments · program years 2020–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $3,716,204 49 payments

Who received the money Research payments · program years 2020–2023

Lucas Research INC Organisation paid for research $702,019 2 payments
Louisville Metabolic and Atherosclerotic Organisation paid for research $538,576 3 payments
Velocity Clinical Research INC Organisation paid for research $530,227 4 payments
Pmg Research INC Organisation paid for research $407,766 3 payments
Allegiance Internal Medicine Specialists Organisation paid for research $395,411 4 payments
Tlm Medical Services LLC Organisation paid for research $331,623 3 payments
Coastal Carolina Research Organisation paid for research $254,618 2 payments
Diablo Clinical Research INC Organisation paid for research $201,640 3 payments
Valley Weight Loss Clinic Organisation paid for research $146,121 4 payments
Washington Center for Weight Organisation paid for research $126,464 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.